By Sonali Smith, MD
The University of Chicago has partnered with Tufts University Medical Center and Northwestern University Feinberg School of Medicine to host the 12th International Ultmann Chicago Lymphoma Symposium. The symposium will be held at the W Chicago City Center hotel, from Friday afternoon, April 24 through Saturday, April 25, 2015.
The International Ultmann Chicago Lymphoma Symposium was originally created in order to honor the achievements of University of Chicago physician Dr. John Ultmann, a pioneer in the treatment of lymphoma, who devoted his life to the understanding of this disease. Dr. Ultmann was particularly known for his work on the staging of Hodgkin lymphoma and the utility of staging as a guide for treatment.
I am a co-chair of the symposium, and was fortunate enough to be mentored by Dr. Ultmann. To this day, I am inspired by his legacy, incredible bedside manner, and passion for the field. The annual symposium is dedicated solely to the science and clinical care of lymphoma.
For us, the symposium facilitates a forum for physicians, researchers, and other allied healthcare professionals to discuss biologic, diagnostic and therapeutic aspects of Hodgkin and non-Hodgkin lymphoma.
As a certified Continuing Medical Education activity, participants will learn about the biologic, diagnostic, and therapeutic aspects of Hodgkin and non-Hodgkin lymphoma through the combination of expert presentations, interactive case discussions, poster/abstract presentations, and question-and-answer debates.
The symposium’s curriculum is designed for medical hematologists/oncologists, radiation oncologists, pathologists, surgical oncologists, fellows-in-training, oncology nurses, and allied health professionals who are committed to the prevention, management, and elimination of lymphoma.
Along with me, the University of Chicago Medicine will be represented by:
- Chadi Nabhan, MD, associate professor of medicine, medical director, Clinical Cancer Center and Cancer Clinics;
- Justin Kline, MD, assistant professor of medicine, Section of Hematology/Oncology.
The invited speakers include many experts and leaders in the field, including Dr. Margaret Shipp from Dana-Farber Cancer Institute and Dr. Michael Hallek from the University of Cologne who will be honored as the Scientific Keynote and Clinical Keynote speakers, respectively. The agenda and planned discussion points are thought provoking, educational, and exciting.
To learn more about this event, please visit our website at http://chicagolymphoma.com.
Sonali Smith, MD, is an associate professor of medicine in the Section of Hematology/Oncology and the director of the Lymphoma Program at the University of Chicago Medicine. Dr. Smith is an expert in the care and treatment of adults with all types of Hodgkin and non-Hodgkin lymphoma. She has a special interest in new agents for lymphoma, as well as stem cell transplantation and its role in improving the survival of patients with relapsed lymphomas. As an active researcher, Dr. Smith is involved in the development of promising agents for patients with non-Hodgkin and Hodgkin lymphoma. She is principal investigator on a number of innovative clinical trials. Dr. Smith serves on several national committees charged with improving treatment options for patients with lymphoma, providing physician education, and providing reliable information for patients through established websites.